,,if I remember correctly,,,,DMcC noted that after the intial dose of 208 in the NZ trial these biomarkers were noted to improve within a few HOURS!....now I know I didnt dream that,,,,, and I am sure a few here would have that time noted mentally as well.

Not sure why RVX cant complie one of their blogs, and detailed, about the possible relationship between apabetalone and covd-19 and how a MOA could be of benefit to patients.

But ,,nope,,,,,Management is not happy unless our share price in the dumper,,,,,,,,,,,,,,,,,I see at end of day yesterday 93,000 shares on the ask at .76. Now that is pitiful!!,,,,,,,,,,,,,as is this team of professionals who cant provide enuff info to the investing public to stir even a tick of irrational exuberance!!